Randomized placebo-controlled study of recombinant human interleukin-11 to prevent chemotherapy-induced thrombocytopenia in patients with breast cancer receiving dose-intensive cyclophosphamide and doxorubicin.

Randomized placebo-controlled study of recombinant human interleukin-11 to prevent chemotherapy-induced thrombocytopenia in patients with breast cancer receiving dose-intensive cyclophosphamide and doxorubicin.

Item
http://www.wikidata.org/entity/Q33500773
Interleukin-11 for induction of remission in Crohn's diseaseInterleukin-11 levels in healthy and thrombocytopenic neonatesThe role of interleukin-11 to prevent chemotherapy-induced thrombocytopenia in patients with solid tumors, lymphoma, acute myeloid leukemia and bone marrow failure syndromesTreatment of lupus-induced thrombocytopenia with recombinant human interleukin-11.Risks, costs, and alternatives to platelet transfusions.Thrombopoietic cytokines in relation to platelet recovery after bone marrow transplantation.Platelet transfusion in the management of severe thrombocytopenia in neonatal intensive care unit patients.Characterization of a potent human interleukin-11 agonistLow-dose interleukin-11 in patients with bone marrow failure: update of the M. D. Anderson Cancer Center experience.A phase II prospective open-label escalating dose trial of recombinant interleukin-11 in mild von Willebrand diseaseMyeloid growth factors in oncology.Immunocytokines: a novel class of products for the treatment of chronic inflammation and autoimmune conditions.Volatile anesthetics and AKI: risks, mechanisms, and a potential therapeutic window.Oral interleukin 11 as a countermeasure to lethal total-body irradiation in a murine model.Mutual cytokine crosstalk between colon cancer cells and microenvironment initiates development of distant metastases.
P2860

Randomized placebo-controlled study of recombinant human interleukin-11 to prevent chemotherapy-induced thrombocytopenia in patients with breast cancer receiving dose-intensive cyclophosphamide and doxorubicin.

Item
http://www.wikidata.org/entity/Q33500773
description
1997 nî lūn-bûn
@nan
1997 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1997 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
name
Randomized placebo-controlled ...... lophosphamide and doxorubicin.
@ast
Randomized placebo-controlled ...... lophosphamide and doxorubicin.
@en
type
label
Randomized placebo-controlled ...... lophosphamide and doxorubicin.
@ast
Randomized placebo-controlled ...... lophosphamide and doxorubicin.
@en
prefLabel
Randomized placebo-controlled ...... lophosphamide and doxorubicin.
@ast
Randomized placebo-controlled ...... lophosphamide and doxorubicin.
@en
P1433
P1476
P2093
P304
P31
P356
P407
P433
P478
P577
P698
P921
P356
P1433
P1476
Randomized placebo-controlled ...... lophosphamide and doxorubicin.
@en
P2093
P304
P31
P356
10.1200/JCO.1997.15.11.3368
P407
P433
P478
P577
P698
P921